WELCOME to the new ModernAesthetics.com

You can find all AestheticsWire, MATV, and Modern Aesthetics® content here!

MA push banner logos
search Created with Sketch.
search Created with Sketch.

Advertisement

Topic: Minimally Invasive

Aesthetics Insider: Crown Laboratories Jeff Bedard thumbnail
Play Button

Aesthetics Insider: Crown Laboratories Jeff Bedard

Series: Aesthetics Insider | January 8, 2020

With a range of OTC skin care products and a growing presence in aesthetics, Crown Laboratories—maker of SkinPen—is dedicated to patient care. President & CEO Jeff Bedard speaks with host Steve Dayan, MD.

Watch Video

News | December 18, 2019

Alastin Skincare Receives Third Patent

Alastin Skincare, Inc. has received a third US Patent  from the United States Patent and Trademark Office. The patent covers Alastin’s innovative science and products. US Patent No. 10,493,011 is entitled, "Peptide...

Read More
Device Talk: Can We Address Cellulite? thumbnail
Play Button

Device Talk: Can We Address Cellulite?

Series: Device Talk | December 16, 2019

The architecture of cellulite leads to its unique appearance and complex treatment. Advancements in device technology allow for better results than ever for dimpling, sagging, and other features of the disease, say Mathew Avram, MD and Jeremy Green, MD. Combination approaches may yield best outcomes.

Watch Video
MATV News: Boxed Warning for Breast Implants; Merz Reorganizes; National Botox Day thumbnail
Play Button

MATV News: Boxed Warning for Breast Implants; Merz Reorganizes; National Botox Day

Series: MATV News | November 22, 2019

The FDA proposes a boxed warning for breast implants, a look at what the Merz reorganization will mean for aesthetic physicians, Dr. Roy Geronemus wins the inaugural ASDS Vic Narurkar, MD, Innovations in Aesthetic Dermatology Lectureship, and Allergan celebrates National Botox Day. Plus, does plastic surgery training have negative effects on reproductive health? 

Watch Video

News | October 23, 2019

Merz: Cellfina for Cellulite Cleared for 5 Years of Benefit

The FDA has cleared a new indication statement for Cellfina that shows the benefits of treatment last for five years, an increase from the previous three-year indication. Cellfina from Merz demonstrated five-year improvement in the...

Read More

Advertisement

The Latest in Minimally Invasive

Advertisement

Advertisement

View more